PharmaShots | Incisive News in 3 Shots

Subscribe Now

ayala pharmaceuticals

Ayala Pharmaceuticals Entered into a Definitive Merger Agreement with Biosight to Advance Oncology Assets Portfolio

Ayala Pharmaceuticals Entered into a Definitive Merger Agreement with Biosight to Advance Oncology Assets Portfolio

July 28, 2023

Ayala Pharmaceuticals Reports First Patient Dosing of AL102 in P-III (RINGSIDE) trial for the Treatment of Desmoid Tumors

Ayala Pharmaceuticals Reports First Patient Dosing of AL102 in P-III (RINGSIDE) trial for the Treatment of Desmoid Tumors

November 17, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us